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WHAT THIS PAPER ADDS 
 Little is known about the most important modifiable factors which are associated with 
absenteeism and presenteeism (work performance) among people with COPD. 
 In this UK primary care cohort, where approximately 18% of people with COPD were in work, 
those with worse dyspnoea were more likely to experience higher absenteeism and poorer 
work performance. Additionally, people with a history of higher occupational exposure to 
vapours, gases, dusts or fumes (VGDF) were more likely to experience poorer work 
performance. 
 This is the first study to comprehensively assess which subject characteristics are associated 
with work productivity in people with COPD; indicating the need to focus on better symptom 
management and reducing workplace exposures to VGDF. 
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ABSTACT 
Background Patients with COPD are more likely to take time off work (absenteeism) and report poor 
performance at work (presenteeism) compared to those without COPD. Little is known about the 
modifiable factors associated with these work productivity outcomes.  
Aim To assess the factors associated with work productivity among COPD patients. 
Methods Cross-sectional analysis of baseline data from a sub-sample (those in paid employment) of 
the Birmingham COPD Cohort Study. Absenteeism was defined by self-report over the previous 12 
months. Presenteeism was assessed using the Stanford Presenteeism Scale (SPS-6). Logistic 
regression analysis was used to assess the effects of socio-demographic, clinical and occupational 
characteristics on work productivity. 
Results Among 348 included participants, increasing dyspnoea was the only factor associated with 
both absenteeism and presenteeism (p for trend<0.01). Additionally, increasing history of 
occupational exposure to vapours, gases, dusts or fumes (VGDF) was independently associated with 
presenteeism (p for trend<0.01).  
Conclusions This is the first study to identify important factors associated with poor work 
productivity among patients with COPD. Future studies should evaluate interventions aimed at 
managing breathlessness and reducing occupational exposures to VGDF on work productivity among 
patients with COPD. 
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INTRODUCTION 
COPD is a progressive lung disease affecting 6-10% of adults worldwide1 with a high morbidity and 
mortality burden.2 Often diagnosed in middle age, a high proportion of those with COPD are of 
working age (~2/3 in the US3 and 40% in the UK4), although paid employment rates are lower 
compared to the general population.5  
There is some evidence that COPD patients who are in paid employment have higher rates of 
absenteeism (time off work) than those without COPD6 or those with other chronic conditions such 
as asthma and cardiovascular disease.7 Furthermore, studies from the US suggest that even when at 
work, some people with COPD have poor work performance (presenteeism) compared to those 
without COPD.8 Indirect societal costs attributable to COPD (largely due to absenteeism) are high 
(~£2.7bn/year in UK9; $3.9bn in the US10). Studies based on other conditions suggest that 
presenteeism costs may exceed those associated with absenteeism.11  
In the general population, poor work productivity (absenteeism and/or presenteeism) is more 
common among women12 and those with a lower education level.13 Occupational factors such as job 
insecurity,14;15 longer working hours (>45h per week)15 and reduced job satisfaction14 are also 
important contributors. However, there may be additional disease specific factors associated with 
poor work productivity among COPD patients. The few available studies examining this question 
have inconsistent findings in relation to disease severity, co-morbidities and absenteeism.16;17 No 
previous study has assessed the factors associated with presenteeism and the relative importance of 
disease related, sociodemographic and occupational factors in relation to poor work productivity is 
not known. 
A better understanding of the modifiable factors influencing work productivity among COPD patients 
could inform future interventions, which in turn, could improve patients’ work experience, thereby 
reducing the burden and societal costs related to COPD. The aim of this study was to evaluate 
factors associated with absenteeism and presenteeism, among working patients with COPD. 
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METHODS 
Study design and participants 
We undertook a cross-sectional analysis of baseline data from the Birmingham COPD Cohort.18 
A total of 1889 patients with COPD from 71 primary care practices across the West Midlands, UK, 
were recruited to the Birmingham COPD Cohort Study during the period June 2012 to July 2014.18  
These included 1558 patients with a previous COPD diagnosis (from GP registers) and 331 newly 
identified COPD patients from a related case finding RCT.19 
For this analysis 348 participants (existing and newly identified) from the cohort who reported they 
were in paid employment or self-employed at baseline were included. 
Measures 
At baseline, participants completed a series of questionnaires to obtain detailed information on their 
health, occupation, lifestyle and socioeconomic circumstances. They also had a range of 
measurements, including spirometry. Relevant measures included for the analysis in this paper are 
outlined in more detail below. 
COPD and clinical characteristics:  
Pre and post-bronchodilator spirometry, was carried out by trained researchers using the Spiroson-
AS flowmeter (ndd, Switzerland) according to ATS/ERS 2005 standards,20 and bespoke software 
(MRM). Post-bronchodilator spirometry was used to assess the severity of airflow obstruction (GOLD 
criteria21). The MRC respiratory questionnaire22 was used to assess the level of dyspnoea, and 
respiratory quality of life was determined using the COPD Assessment Test (CAT).23 The number of 
exacerbations over the previous 12 months was assessed by self-report (steroid or antibiotic 
treatment for an exacerbation in the previous 12 months). 
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Occupational characteristics and exposures:  
We obtained data on current occupation using a  questionnaire administered by trained research 
assistants, who used information on skill content and skill level to assign a 4-digit standard 
occupational classification (SOC 2010) code using the CASCOT (computer assisted structured coding 
tool) software.24 A job exposure matrix (JEM)25 (adapted to SOC 2010 codes by the author of the ACE 
JEM25) was used to assign the level of airborne exposure (none, low, medium or high) of 
occupational exposures to vapours, gases, dusts or fumes (VGDF) for each SOC code. The ACE JEM 
assigns occupational exposures to SOC codes independent of respiratory outcomes. 
Where possible, validated questionnaires were used to collect information on: working hours26; job 
satisfaction26; job training over previous 12m (excluding health and safety training)26; supervising 
other employees26; type of contract26; length in current employment26; work involving 
walking/standing; work involving manual/physical work and usual shift pattern. 
Work productivity measures 
Absenteeism:  
Participants who reported having taken any time off work during the previous 12 months were 
classified as exhibiting absenteeism. The reason (respiratory, other health problems or other) and 
duration of any absenteeism were also noted. Absenteeism was further categorised into “low” (0 to 
5 days) or “high” (> 6 days) using the average number of days off work among UK employees (4.4 
days) to inform the cut-off.27  
Presenteeism:  
The Stanford Presenteeism Scale (SPS-6) was used to assess the impact of the participant’s “chest 
problems” on their work performance over the previous month.28 The scale results in scores 
between 6 and 30, with lower scores indicating a greater disease impact on work performance (i.e. 
poorer work performance and high presenteeism).28 However, the scale does not have validated 
categories to define the level of presenteeism e.g. low, medium or high. Furthermore, the 
differences in SPS-6 scores are ambiguous, leading to a lack of clarity when interpreting the data.  
Consequently, the lower and upper quartiles of the distribution of presenteeism scores in the cohort 
population was used to categorise participants into those with high (SPS-6 score ≤19), or low (SPS-6 
score >28) presenteeism. 
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Other measures 
Validated questionnaires were used to collect information on smoking status, comorbidities (self-
report of physician diagnosed disease) educational level and gross income. Information on age, sex, 
height and weight were obtained by trained research assistants. Social deprivation was measured 
using the Index of Multiple Deprivation (IMD) 2010 score based on participant home postcodes.29  
Sample sizes 
We had estimated that 200 COPD patients should be sufficient to detect a relative risk of 2.5 for 
absenteeism among those with more severe COPD compared to those with mild disease (80% 
power; 5% confidence), and that this sample size would allow us to detect standardised effect sizes 
of at least 0.45 for presenteeism, comparing the least with most severe COPD (80% power; 5% 
confidence).   Thus we acknowledge that the study had power to detect only relatively large effect 
sizes, but we were limited by the size of the overall cohort. 
Statistical analysis 
Univariate and multivariable logistic regression analyses were undertaken in STATA version 13.0 to 
assess: (1) the risk of having high levels of absenteeism (>6 days) and (2) the risk of having poor work 
performance (SPS-6 score ≤19). Statistically and clinically important variables were included in the 
models. The first model included known clinically important covariates: age, sex, smoking status, 
GOLD stage and number of co-morbidities. Using the likelihood ratio test, the contributions of the 
statistically significant clinical and occupational covariates identified in the univariate analyses were 
assessed. 
Additional analyses  
The relationship between absenteeism and presenteeism was assessed by correlation and 
comparing the pre-defined categories. 
Sensitivity analyses explored using various cut-off points to denote high absenteeism (4, 5, 7 and 8 
days), and presenteeism (SPS-6 score <18, as suggested by previous research,30  or using the median: 
SPS-6 score <24). A separate analysis of specific COPD related absenteeism was also conducted.  
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RESULTS 
Characteristics of the participants 
Of the 7176 eligible patients, 1889 (26.3%) consented to taking part in the Birmingham COPD Cohort 
Study; of whom 348 (18.4%) were employed and form the subgroup we studied (Figure 1).  
Sociodemographic and clinical characteristics 
A high proportion of the participants were male (62.4%), of working age (<65 years: 71.3%) and ever-
smokers (91.3%) (Table 1). The majority were either overweight or obese (68.5%) and had >1 co-
morbidity (83.0%). The most common co-morbidities included cardiovascular disease (45.5%), 
allergies (39.9%), depression (24.0%) and gastrointestinal disease (21.8%). 
Based on the MRC dyspnoea score, health related quality of life and level of airflow obstruction, 
most participants had mild to moderate COPD, although over half reported one or more 
exacerbations in the previous year (supplementary Table S1).  
Occupational characteristics 
Participants were from a range of occupational backgrounds and industries/organisations (see Table 
1 and supplementary Table S2). The majority (79.5%) had no or low occupational exposures to VGDF 
(Table 1). In a sub-sample of 91 participants where the information was available, approximately 
20% were self-employed. The majority of participants had jobs which involved either 
walking/standing (82.3%) or manual/physical work (57.4%). Most participants had a permanent job 
role (n=281; 85.7%) and worked a regular daytime schedule (n=234; 71.8%).  
There were some differences in characteristics between men and women, particularly in type of 
comorbidities (more cardiovascular disease in men) and occupational factors (men more likely to be 
self-employed, work >37 hours and higher workplace VGDF exposure).  
There were also some differences in characteristics between those of working age (<65 years) and 
those >65 years: older workers were more likely to have a lower level of education (51.5% vs. 
71.9%), work less than 20 hours per week (8.9% vs. 35.2%) and work in the following occupational 
backgrounds: caring, leisure and other services (10.7% vs. 14.2%) sales and customer service (4.6% 
vs. 7.1%) and elementary (14.5% vs. 19.2%). However there was no difference between the groups 
in terms of the proportion who were self-employed. 
 
 
8 
 
Sociodemographic, lifestyle and clinical 
characteristics 
Participants with 
COPD in paid 
employment 
n=348 
Sex  
Male 217 (62.4%) 
Female 131 (37.6%) 
Age categories (years)  
38 – 49 38 (10.9%) 
50 – 59 122 (35.1%) 
60 - 64 88 (25.3%) 
>65 100 (28.7%) 
Smoking status  
Never smoked 28 (8.7%) 
Ex-smoker 161 (50.0%) 
Current smoker 133 (41.3%) 
Education level  
Degree or higher level 53 (19.8%) 
A level/AS level or equivalent 26 (9.7%) 
GCSE, CSE, O level or equivalent 84 (31.3%) 
No formal qualification 105 (39.2%) 
Disease severity (GOLD stage criteria)  
Mild 117 (34.8%) 
Moderate 171 (50.9%) 
Severe and very severe 48 (14.3%) 
Co-morbidities  
Cardiovascular disease 140 (45.5%) 
Diabetes 33 (10.7%) 
Gastrointestinal disease 72 (21.8%) 
Cancer 27 (8.7%) 
Depression 74 (24.0%) 
Osteoarthritis 32 (10.5%) 
Rheumatoid arthritis 24 (8.0%) 
Allergies (hayfever, eczema and other) 87 (69.6%) 
Occupational background (SOC 2010)  
Managers, directors and senior officials 40 (11.7%) 
Professional 40 (11.7%) 
Associate professional and technical 29 (8.5%) 
Administrative and secretarial 34 (10.0%) 
Skilled trade 42 (12.3%) 
Caring, leisure and other services 40 (11.7%) 
Sales and customer service 18 (5.3%) 
Process, plant and machine operatives 44 (12.9%) 
Elementary 54 (15.8%) 
Exposures to VGDF  
None 154 (45.4%) 
Low 114 (33.6%) 
Medium and high 71 (20.9%) 
Table 1 Sociodemographic, lifestyle and clinical characteristics of the participants in the 
occupational sub-cohort  
Increasing 
severity 
Increasing airborne 
occupational exposure 
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Absenteeism  
Absenteeism data were available for 270 (77.6%) participants. Overall 44.3% (n=154) reported work 
absence in the previous 12m, ranging from 1 to 365 days (mean 27.9 (SD 63.9), median 7 (IQR 3 to 
21)), and 59 (17.0%) reported COPD related absenteeism. In the total working population with 
complete data (n=270), 216 had low (0 to 5 days) and 54 (16.7%) high absenteeism (>6 days) with 
mean 10.4 (SD 41.3) and median 0 (IQR 0 to 4) absence days. 
Presenteeism  
There were 301/348 (86.5%) participants with data on presenteeism with mean (SD) and median 
(IQR) SPS-6 scores 23.5 (5.0) and 24.0 (19 to 28), respectively. 77 participants were categorised as 
having little/no presenteeism and 82 participants as high presenteeism.  
Relationship between absenteeism and presenteeism 
Data on both absenteeism and presenteeism were available for 249 (71.6%) participants and 
measures were weakly correlated (r= -0.14; p=0.03). Comparison of dichotomised categories showed 
non-concordance in 34% (n=85) of participants. Thus, 13% (n=33) with high absenteeism, had low 
presenteeism when at work and 21% (n=52) with high presenteeism had little or no absenteeism.  
 
Factors associated with absenteeism 
High all-cause absenteeism was more common in those with ≥1 comorbidity, and there were 
positive dose-response relationships with increasing breathlessness (p for trend<0.01); CAT score 
(poorer quality of life) (p for trend=0.08); airflow obstruction (p for trend=0.38) and number of 
exacerbations (p for trend<0.01). High absenteeism was also more likely among women, ever 
smokers and those with lower income levels, and also among those with professional occupations, 
with occupations which always/usually involved walking/standing and had length of employment >5 
years, although none of these differences were statistically significant. Compared to those working 
30 hours or more per week, participants reporting between 20 to less than 30 hours work per week 
were more likely to experience high absenteeism (p<0.05), whereas participants working less than 
20 hours per week were less likely to have high absenteeism (not significant).  There was no 
apparent relationship between occupational exposures to VGDF or job satisfaction and absenteeism 
(see supplementary Table S3).  
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In the final multivariable model, age (50 – 59 years), increasing dyspnoea (p for trend<0.01) and 
working hours (20 to <30 hours) were significantly associated with high absenteeism (Table 2). No 
association was found between absenteeism and airflow obstruction or any other clinical factors. 
 
Additional analyses 
Irrespective of the cut-off points used to denote high absenteeism, the overall patterns of 
associations remained as for the main analysis. The patterns also remained when considering COPD-
related absenteeism, although the relationship with airflow obstruction (severe to very severe 
adjusted OR=3.63; 95% CI: 1.18-11.15) and being female (OR=2.11; 95% CI: 1.02-4.35) became 
statistically significant, whilst the association with age and working hours became non-significant.  
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Characteristics 
Number (%) 
with high 
absenteeism 
n=54 
Univariate model 
ORs (95% CI) for risk 
of high absenteeism 
Final multivariable 
model  
ORs* (95% CI) for risk 
of high absenteeism 
Sex    
Male (%) 29 (17.1%) 1.0 1.0 
Female (%) 25 (25.0%) 1.62 (0.89 – 2.96) 2.02 (0.83 – 4.90) 
Age categories    
38 – 49 3 (10.7%) 1.0 1.0 
50 – 59 25 (26.9%) 3.06 (0.85 – 11.04) 6.04 (1.04 – 35.04) 
60 - 64 11 (17.2%) 1.73 (0.44 – 6.75) 3.02 (0.46 – 19.61) 
>65 15 (17.7%) 1.79 (1.48 – 6.69) 3.74 (0.56 – 24.89) 
Smoking status    
Never smoked 2 (10.0%) 1.0 1.0 
Ever smoker 50 (21.3%) 2.43 (0.55 – 10.84) 5.71 (0.48 – 68.09) 
IMD score quintiles    
1 7 (12.1%) 1.0 1.0 
2 12 (20.3%) 1.86 (0.68 – 5.12) 1.16 (0.30 – 4.57) 
3 13 (22.4%) 2.10 (0.77 – 5.74) 1.54 (0.43 – 5.58) 
4 13 (21.1%) 1.94 (0.70 – 5.36) 1.16 (0.28 – 4.80) 
5 10 (28.6%) 2.91 (0.99 – 8.56) 1.69 (0.40 – 7.22) 
Number of co-morbidities    
0 3 (6.7%) 1.0 1.0 
1+ 51 (22.7%) 4.10 (1.22 – 13.79) 2.36 (0.56 – 9.94) 
MRC Dyspnoea score    
1 13 (15.5%) 1.0 1.0 
2 6 (17.5%) 0.44 (0.16 – 1.23) 0.46 (0.12 – 1.78) 
3 16 (23.9%) 1.71 (0.76 – 3.87) 2.11 (0.72 – 6.24) 
4 and 5 17 (54.8%) 6.63 (2.64 – 16.67) 13.83 (3.78 – 50.56) 
Severity of airflow obstruction (GOLD stage 
criteria) 
   
Mild 16 (17.2%) 1.0 1.0 
Moderate 27 (20.0%) 1.20 (0.61 – 2.38) 1.00 (0.39 – 2.58) 
Severe and very severe 8 (24.2%) 1.54 (0.59 – 4.03) 1.84 (0.54 – 6.27) 
Usual working hours    
>30 hours 33 (19.1%) 1.0 1.0 
20 to <30 hours 15 (36.6%) 2.45 (1.17 – 5.13) 2.92 (1.07 – 7.97) 
<20 hours 3 (7.5%) 0.34 (0.10 – 0.34) 0.27 (0.06 – 1.25) 
 
*Multivariable model includes: sex, age, smoking status, social deprivation (IMD score), number of co-morbidities, MRC score 
and airflow obstruction  
 
 
 
Table 2 Association between socio-demographic, clinical and occupational characteristics and risk of 
high absenteeism among COPD participants 
Increasing 
deprivation 
Increasing 
severity 
Increasing 
breathlessness 
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Factors associated with presenteeism  
In the univariate analyses (Table 3), increasing breathlessness (p for trend<0.01), CAT score (lower 
QOL (p for trend<0.01) and number of exacerbations (p for trend<0.05) were all associated with 
poor work performance (higher presenteeism). There were also non-significant trends towards 
poorer work performance among current smokers, those with a lower educational level, a lower 
income, a higher deprivation score, those who were overweight or obese and those with ≥1 
comorbidity (OR=1.53; 95% CI 0.67 – 3.49). Those with jobs which usually/always required 
walking/standing or manual/physical work were more likely to report poor work performance 
(although associations were not statistically significant). A positive dose-response relationship was 
noted between increasing exposure to VGDF and increased probability of reporting poor work 
performance (p for trend<0.01). In contrast, those employed for >5 years were less likely to 
experience poor work performance (non-significant) (see supplementary Table S4). No apparent 
associations were found between working hours and poor work performance.  
In the final multivariable model, increasing dyspnoea (p for trend<0.01) and exposures to VGDF (p 
for trend<0.01) remained independently associated with poor work performance (Table 3). The 
presence of co-morbidities and being a current smoker increased the risk of reporting poor work 
performance, although these effects did not reach statistical significance.  
 
Additional analyses 
In the analyses focussing on the effect of the two alternative cut off points to denote poor work 
performance (SPS-6 score: <18 and <24) the overall patterns remained the same, although not all 
were statistically significant.  
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Baseline characteristics 
Number (%) with poor 
work performance 
(SPS-6 score <19) 
n=82 
Univariate model  
ORs (95% CI) for risk 
of having poorer work 
performance 
Final multivariable 
model  
ORs* (95% CI) for risk 
of having poorer work 
performance 
Sex    
Female (%) 28 (48.3%) 1.0 1.0 
Male (%) 54 (53.5%) 1.23 (0.65 – 2.35) 0.71 (0.28 – 1.81) 
Age categories:    
38 – 49 10 (52.6%) 1.0 1.0 
50 – 59 27 (49.1%) 0.87 (0.31 – 2.47) 0.36 (0.08 – 1.68) 
60 - 64 18 (56.3%) 1.16 (0.37 – 3.62) 1.15 (0.22 – 6.11) 
>65 27 (50.9%) 0.93 (0.33 – 2.67) 0.41 (0.08 – 2.12) 
Smoking status    
Never smoked 6 (42.9%) 1.0 1.0 
Ex-smoker 39 (47.0%) 1.18 (0.38 – 3.71) 2.28 (0.44 – 11.69) 
Current smoker 32 (60.4%) 2.03 (0.62 – 6.70) 3.39 (0.64 – 17.99) 
IMD score quintiles    
1 13 (35.1%) 1.0 1.0 
2 21 (52.5%) 2.04 (0.82 – 5.10) 2.56 (0.76 – 8.63) 
3 20 (60.6%) 2.84 (1.08 – 7.51) 3.01 (0.85 – 10.68) 
4 16 (55.2%) 2.27 (0.84 – 6.15) 2.15 (0.54 – 8.54) 
5 11 (57.9%) 2.54 (0.82 – 7.89) 2.22 (0.45 – 11.00) 
Number of co-morbidities    
0 12 (42.9%) 1.0 1.0 
1+  70 (53.4%)  1.53 (0.67 – 3.49) 2.15 (0.67 – 6.86) 
MRC    
1 20 (40.8%) 1.0 1.0 
2 15 (34.9%) 0.78 (0.33 – 1.81) 0.83 (0.28 – 2.48) 
3 21 (55.3%) 1.79 (0.76 – 4.22) 2.65 (0.88 – 7.95) 
4 and 5  23 (92.0%)  16.67 (3.53 – 78.81) 18.11 (2.93 – 112.21) 
Severity of airflow obstruction 
(GOLD stage criteria) 
   
Mild 23 (45.1%) 1.0 1.0 
Moderate 46 (56.8%) 1.60 (0.79 – 3.24) 1.08 (0.40 – 2.90) 
Severe and very severe 11 (50.0%) 1.22 (0.45 – 3.31) 1.03 (0.26 – 4.09) 
Exposures to VGDF    
None 27 (38.6%) 1.0 1.0 
Low 34 (60.7%) 2.46 (1.20 – 5.06) 3.50 (1.25 – 9.79) 
Medium and high 21 (67.7%) 3.34 (1.37 – 8.17) 4.34 (1.26 – 14.93) 
Length of employment in current 
workplace 
   
< 5 years 26 (61.9%) 1.0 1.0 
>5 years 55 (48.7%) 0.58 (0.28 – 1.20) 0.45 (0.15 – 1.29) 
 
*Multivariable model includes: sex, age, smoking status, social deprivation (IMD score), number of co-morbidities, MRC score, 
airflow obstruction, occupational exposures to VGDF and length of employment 
 
 
Table 3 Association between socio-demographic, clinical and occupational characteristics and risk of 
poor work performance (presenteeism) among COPD participants 
Increasing 
deprivation 
Increasing 
severity 
Increasing 
breathlessness 
Increasing 
occupational 
airborne 
exposure 
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DISCUSSION 
Key results 
In this primary care working COPD population with predominantly mild to moderate airflow 
obstruction, there were relatively high rates of absenteeism, with over one in six participants 
(17.6%) reporting ≥6 absence days over the previous 12 months. In contrast we found low 
presenteeism rates, suggesting that when at work, COPD patients generally function well.  
This study clarifies the most important factors affecting absenteeism and presenteeism in a broadly 
representative cohort of COPD patients from a UK primary care setting, where previous studies have 
shown inconsistency in the factors associated with absenteeism and no studies have assessed the 
factors associated with presenteeism. 
The only common risk factor significantly associated with both absenteeism and presenteeism was 
the level of dyspnoea. Working between 20 and 29 hours and age 50 – 59 years were associated 
with higher levels of absenteeism. No other markers of disease severity or other factors examined 
were associated with all-cause absenteeism, though being female and increased severity of airflow 
obstruction were additional factors associated with COPD-related absenteeism. There was however, 
a clear association between higher exposures to VGDF and greater presenteeism.   
Although 6.4% of participants had both high absenteeism and presenteeism, over a third had only 
either high absenteeism or high presenteeism; suggesting these measures reflect different aspects 
of work productivity. 
Findings in relation to other studies 
Our finding that participants with COPD had a mean of 10.4 absence days in the previous 12 months 
(compared with the UK national mean of 4.4 days27), confirms the higher rates of absenteeism 
among people with COPD reported in other studies.6;8  
Conversely we found that on average, presenteeism levels were low (mean SPS-6 score 23.5; SD 5.0) 
compared to those with arthritis (mean SPS-6 score 13.3; SD 5.2)31 and comparable to employees 
reporting no disability (mean SPS-6 score 23.5; SD 3.8),28 and patients with cystic fibrosis  (mean SPS-
6 score 25.1).32  
The observed relationship between increasing dyspnoea and absenteeism and presenteeism confirm 
similar findings reported in a large international cross-sectional survey.33 Our findings suggest a 
significant relationship between increasing airflow obstruction and COPD related absenteeism, but 
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not all-cause absenteeism, which may explain conflicting results from other studies exploring this 
association.16;34  
Our findings that age and working hours are associated with the risk of sickness absence are 
consistent with research in the general population. Data from the Office for National Statistics 
indicate increases in sickness absence with increasing age, until the state pension age, which is 
followed by a decline in sickness absence rates.27 Furthermore, whilst there is evidence to suggest 
that those working <30 hours per week have more days off work compared to full time workers,35 
employees working much fewer hours (<16 hours) have lower sickness absence rates27;36 – similar to 
the trends observed in our study.  
Other studies have reported that the presence of co-morbidities and smoking are associated with 
poor work productivity in the general population,11;37 in those with health conditions37;38 and 
amongst patients with COPD.17 We found similar trends, but these associations were not statistically 
significant, possibly because of the small numbers of non-smokers and high proportion with co-
morbidities relative to the sample size. 
Clear associations between exposure to VGDF and respiratory related absenteeism have been 
demonstrated among an asthmatic population (OR=1.96; 95% CI 1.06 – 3.64), and those with 
respiratory symptoms (OR=2.20; 95% CI 1.01 – 4.77).39 This was not observed in our study sample, 
although the wide CIs suggest there may not have been sufficient power to detect any effects. In 
contrast, we found that increasing exposure to VGDF was associated with greater presenteeism, 
which has not been previously reported in patients with COPD. A number of other occupational 
characteristics (such as job satisfaction, working hours, lack of supportive work culture and size of 
organisation) that have been shown to be associated with work productivity in other studies14;15 
were not observed in our sample, possibly due to the limited sample size, or the way these 
characteristics were assessed. 
Definitions and instruments used to assess absenteeism and presenteeism vary widely within this 
emerging field of research, and the various terms defining presenteeism have often been used inter-
changeably.14 Although there is correlation between absenteeism and presenteeism, the latter may 
be a stronger predictor of poor health,14 and we demonstrated that the two measures assess 
different facets of work productivity. 
In a separate analysis, examining the factors associated with the likelihood of being employed 
among patients with COPD, we found the same characteristics as those identified in this study 
(increasing dyspnoea and workplace exposures to VGDF) were important.40 This suggests there may 
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be a continuum; from impact on work productivity among those in paid employment, to 
unemployment among the most severely affected. 
Strengths and limitations 
This is the first study to assess the impact of COPD on work productivity and characteristics 
associated with poor work performance, in a primary care population with predominantly mild to 
moderate COPD. Participants included those from a wide range of backgrounds and occupations and 
we had data on a wide range of socio-economic, clinical and occupational factors. However, due to 
low participation in the Birmingham COPD Cohort Study (26.3%), the study sample may not be 
completely representative of the full range of patients with COPD who are in paid employment, 
although observed associations should still hold.  
Approximately one quarter (n=80; 23.4%) of the sub-cohort were in occupational groups 
managers/directors/senior officials and professionals, which is lower than the UK national rate 
(31.0%).41 These occupational groups are associated with lower sickness absence rates.27 
Furthermore, the Birmingham COPD Cohort is based within the West Midlands: a region with higher 
unemployment rates (5.6% vs. 4.7%) than the UK national average.42 These higher rates may impact 
on workers’ economic insecurity,43 particularly the fear of job loss; leading to some sub-cohort 
workers opting to take less time off work.44 
A novelty of the Birmingham COPD Cohort, and this sub-cohort, is the inclusion of the newly 
identified COPD patients; an under-represented population in previous COPD cohort studies. This 
has provided the opportunity to include patients who are younger, with less severe disease, who are 
more likely to be in paid employment than those on the GP registries with an existing COPD 
diagnosis.45 Furthermore, a novel finding of this study was the relationship between higher 
occupational exposure to VGDF and poorer work performance, using a standardized JEM to measure 
the level of airborne exposures in the workplace.25  
The study also has limitations. The cross-sectional nature precludes the ability to draw inferences on 
causality. Whilst compared to other studies, we included a large sample of participants, the wide 
confidence intervals for a number of estimates indicate that there was insufficient power to clarify 
associations. Factors such as income and exacerbations (absenteeism model only) were important in 
the univariate analyses, however, as they are susceptible to reverse causation they were not 
included in the final models. 
Absenteeism was based on self-report; which is susceptible to under-reporting due to recall error46 
and social desirability bias.47 This could affect the estimate of absenteeism rates, but is unlikely to 
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bias the observed relationship between absenteeism and other factors. Some other covariates e.g. 
number of co-morbidities; were also based on self-report, possibly introducing errors in prevalence 
rates and diluting the findings. Additionally, there was a low response rate for number of 
absenteeism days and some other measures (e.g. smoking status, job satisfaction), which may have 
led to less reliable estimates. Data on employment type (employed/self-employed) was available in 
only a small sub-sample of the population and could not be assessed in the final analysis, although 
other studies have shown this to be associated with absenteeism.27  
Implications for practice and research 
Our finding that level of dyspnoea is associated with work performance highlights the importance of 
improving the management of breathlessness in COPD patients, particularly those in employment. 
Workplace adaptations with guidance from occupational health (OH) services, self-management 
advice, referral to pulmonary rehabilitation and smoking cessation advice could support symptom 
management.  
OH assessment and advice (altering job role, job tasks or work environment) could also help modify 
exposures to VGDF and contribute to improved work productivity.  
Further studies, including longitudinal studies that assess both absenteeism and presenteeism are 
needed to confirm our findings. Intervention studies are also needed to assess the effectiveness of 
interventions for managing dyspnoea and reducing workplace exposures on work productivity 
among patients with COPD. 
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